Newsfiscal.ai
Precision BioSciences Reports Third Quarter 2026 Financial Results and Business Update
· Published
Article summary
Precision BioSciences announced its financial results for the third quarter ended September 30, 2026, and provided updates on its clinical pipeline, including the PBGENE-HBV and PBGENE-DMD programs.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…